The Effects of Filgrastim on Complications of Patients with Cerebral Hemorrhage Due To Head Trauma
DOI:
https://doi.org/10.3889/oamjms.2018.412Keywords:
Filgrastim, Brain Trauma, ComplicationsAbstract
BACKGROUND: Filgrastim, a neopogen brand, is a blood-forming agent and a natural protein in the body that plays a role in stimulating the growth of white blood cells and protecting them against infectious agents. To the best of knowledge, human and animal specimens have shown the effect of Filgrastim on treating brain injuries regarding bone marrow transfusion into the blood, neuroprotection, stimulation of neurons for forming new neural networks and reducing the risk of bacterial infections.
AIM: This study aimed to investigate the effect of Filgrastim on the prognosis of a cerebral haemorrhage in patients with traumatic brain injury.
METHODS: This study was conducted as a clinical trial, in which the initial diagnosis of patients with cerebral haemorrhage due to head trauma was performed with a clinical examination and CT scan. After the patient arrives at the emergency room, the patient's initial examination is performed, and blood tests are taken from the patient. Moreover, CBC values (Hb, Platelet, Hematocrit) were checked and recorded in the checklist. The intervention group received 150 mcg/day Filgrastim injected subcutaneously for 4 days. Furthermore, patients in the control group received the same amount of sterile water. At the end of the treatment period, blood tests were performed again in all patients, and their results were then recorded. All data were analysed by SPSS v.21 software package.
RESULTS: Our findings revealed that the mean volume of bleeding in the intervention group based on CT scan was significantly reduced after four days as compared to the control group. Moreover, the mean score of consciousness and muscular strength of patients in the intervention group was significantly higher than the control group. Also, WBCs in the intervention group exhibited a significant increase after four days of intervention, while platelet and hematocrit levels in the intervention group decreased significantly compared to the control group.
CONCLUSION: Regarding the results, the therapeutic application of filtration is considered to be effective. Given the lack of serious complications of the proposed dosages, the use of this drug can be suggested.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Margolick J, Dandurand C, Duncan K, Chen W, Evans DC, Sekhon MS, Garraway N, Griesdale DEG, Gooderham P, Hameed SM. A Systematic Review of the Risks and Benefits of Venous Thromboembolism Prophylaxis in Traumatic Brain Injury. Can J Neurol Sci. 2018; 13:1-13. https://doi.org/10.1017/cjn.2017.275
Youmans JR, Becher DP, Dunsker SB, Friedman WA, Hoffman HJj, Smith RR e, et al. Neurological surgery 4th ed. Philadelphia Sanders. 1996; 3:1557-8
Gopinath SP, Robertson CS, Contant CF, Narayan RK, Grossman RG, Chance B. Early detection of delayed traumatic intracranial hematomas using near-infrared spectroscopy. Journal of neurosurgery. 1995; 83(3):438-44. https://doi.org/10.3171/jns.1995.83.3.0438 PMid:7666220
Cooper P. Delayed traumatic intracerebral haemorrhage. Neurosurgery clinics of North America. 1992; 3(3):659-65. https://doi.org/10.1016/S1042-3680(18)30654-5
Iuvara-Bommeli A, de Tribolet N. [Delayed intracranial hematomas following cranio-cerebral trauma]. Schweizerische medizinische Wochenschrift. 1991; 121(18):646-52. PMid:2047825
Dale DC. Colony-stimulating factors for the management of neutropenia in cancer patients. Drugs. 2002; 62(1):1-15. https://doi.org/10.2165/00003495-200262001-00001 PMid:12479591
Welte K. G-CSF: filgrastim, lenograstim and biosimilars. Expert Opin Biol Ther. 2014; 14(7):983-93. https://doi.org/10.1517/14712598.2014.905537 PMid:24707817
Heard SO, Fink MP, Gamelli RL, Solomkin JS, Joshi M, Trask AL, et al. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral haemorrhage. Critical care medicine. 1998; 26(4):748-54. https://doi.org/10.1097/00003246-199804000-00027 PMid:9559614
Andelic N, Sigurdardottir S, Brunborg C, Roe C. Incidence of hospital-treated traumatic brain injury in the Oslo population. Neuroepidemiology. 2008; 30(2):120-8. https://doi.org/10.1159/000120025 PMid:18334828
Effect of Epigallocatechin-3-Gallate Supplementation on Glasgow Coma Score Scale of Patients with Traumatic Brain Injury. The-Neuroscience-Journal-of-Shefaye-Khatam. 2016; 4(4):61-6. https://doi.org/10.18869/acadpub.shefa.4.4.61
Ribah Adnan; Adeleh Hashemi fard; Seyyed Ehsan Saffari. The Effective Factors on the number of hospitalization days for MI patients in Vasei hospital of Sabzevar in 2012 using regression models. Journal of Sabzevar University of Medical Sciences. 2014; 20(4):447-456.
Hardemark HG, Wesslen N, Persson L. Influence of clinical factors, CT findings and early management on outcome in supratentorial intracerebral hemorrhage. Cerebrovascular diseases (Basel, Switzerland). 1999; 9(1):10-21. https://doi.org/10.1159/000015890 PMid:9873158
Shabiri E, Saeidi Bourojeni HR, Rezaei M, Jahanbakhshi A. Relationship of CT scan findings with consciousness, surgical findings and the fate of patients with traumatic intracranial hemorrhage. Journal of kermanshah university of medical sciences. 2014; 18(3):165-172.
Von Eisenhart-Rothe RM, Jäger A, Englmeier K-H, Vogl TJ, Graichen H. Relevance of arm position and muscle activity on three-dimensional glenohumeral translation in patients with traumatic and atraumatic shoulder instability. The American Journal of Sports Medicine. 2002; 30(4):514-22. https://doi.org/10.1177/03635465020300041101 PMid:12130406
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Morteza Qaribi, Arash Yazdanbakhsh, Koorosh Ahmadi, Mohammad Reza Maghsoudi, Vagefe Farshin, Ali Ahmadi, Abolfazl Jokar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0